HC Wainwright Reaffirms Buy Rating for Voyager Therapeutics (NASDAQ:VYGR)
Voyager Therapeutics (NASDAQ:VYGR – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at HC Wainwright in a research note issued on Thursday, Benzinga reports. They currently have a $30.00 price objective on the stock. HC Wainwright’s price objective would suggest a potential upside of 358.02% from the stock’s current price. Other […]
24 Oct 19:38 · The Markets Daily